NCL Inhibition Exerts Antineoplastic Effects against Prostate Cancer Cells by Modulating Oncogenic MicroRNAs is a research paper published in Cancers (2020). On theSindex it has a DataRank of 0. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Grant: P30CA016058
National Institutes of Health
Grant: NIH R35CA197706
National Institutes of Health
Grant: 3P30CA016058-15S1
CORE--HORMONE RECEPTOR LABORATORY
National Institutes of Health
Grant: 5R35CA197706-04
Cancer Gene Discovery to Identify Targetable Targets
NCI NIH HHS
Grant: R35 CA197706
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals